BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
+48.4%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.76B
AUM Growth
+$1.76B
(+28%)
Cap. Flow
-$39.7M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
60.94%
Holding
60
New
12
Increased
10
Reduced
5
Closed
10
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$57.1M |
| 2 |
Direxion Daily S&P Biotech Bear 3X Shares
LABD
|
$35.6M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$31.7M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$25.3M |
| 5 |
Cabaletta Bio
CABA
|
$21.9M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$160M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$53.1M |
| 3 |
Sarepta Therapeutics
SRPT
|
$41.9M |
| 4 |
PTC Therapeutics
PTCT
|
$33.8M |
| 5 |
Wave Life Sciences
WVE
|
$20.5M |
Sector Composition
| 1 | Healthcare | 81.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $221M | 12.5% | 1,715,560 | – | – |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $179M | 10.11% | 8,450,000 +1,500,000 | +22% | +$31.7M |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $153M | 8.67% | 925,000 | – | – |
|
|
ODT
4
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $109M | 6.17% | 3,363,377 | – | – |
|
|
MDCO
5
DELISTED
Medicines Co
MDCO
| $82.1M | 4.65% | 967,000 +217,000 | +29% | +$18.4M |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $79.9M | 4.52% | 2,075,905 | – | – |
|
|
DBVT
7
DBV Technologies
DBVT
$264M
| $68.3M | 3.86% | 6,384,598 +1,084,598 | +20% | +$11.6M |
|
|
ALLK
8
DELISTED
Allakos
ALLK
| $64.4M | 3.64% | 675,000 | – | – |
|
9
Esperion Therapeutics
ESPR
$448M
| $58.1M | 3.29% | 975,000 | – | – |
|
|
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
| $57.1M | 3.23% | +500,000 | New | +$57.1M |
|
11
uniQure
QURE
$896M
| $54.8M | 3.1% | 765,400 -100,000 | -12% | -$7.17M |
|
|
12
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$68.5M
| $35.6M | 2.02% | +2,885,000 | New | +$35.6M |
|
13
Gossamer Bio
GOSS
$562M
| $34.2M | 1.93% | 2,185,000 +110,000 | +5% | +$1.72M |
|
14
Rocket Pharmaceuticals
RCKT
$354M
| $33.4M | 1.89% | 1,466,051 | – | – |
|
15
argenx
ARGX
$43.6B
| $32.1M | 1.82% | 200,000 | – | – |
|
|
16
Sarepta Therapeutics
SRPT
$1.78B
| $29M | 1.64% | 225,000 -325,000 | -59% | -$41.9M |
|
|
KDMN
17
DELISTED
Kadmon Holdings, Inc.
KDMN
| $28.1M | 1.59% | 6,205,882 +2,205,882 | +55% | +$9.99M |
|
|
BCEL
18
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $26.8M | 1.52% | 1,733,583 | – | – |
|
|
SAGE
19
DELISTED
Sage Therapeutics
SAGE
| $25.3M | 1.43% | +350,000 | New | +$25.3M |
|
20
Apellis Pharmaceuticals
APLS
$3.48B
| $24.5M | 1.39% | 800,000 +100,000 | +14% | +$3.06M |
|
21
Matinas BioPharma
MTNB
$10.1M
| $23.1M | 1.31% | 10,188,312 | – | – |
|
22
Amicus Therapeutics
FOLD
$2.34B
| $22.6M | 1.28% | 2,325,000 | – | – |
|
|
23
Cabaletta Bio
CABA
$133M
| $21.9M | 1.24% | +1,566,361 | New | +$21.9M |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $21.1M | 1.2% | 250,000 -200,000 | -44% | -$16.9M |
|
25
AnaptysBio
ANAB
$569M
| $21.1M | 1.19% | +1,300,000 | New | +$21.1M |
|